Skip to main content

Journal of Hematology & Oncology

Collections open for submissions

Deepak Sethi / Getty Images / iStock.

Deepak Sethi / Getty Images / iStock.

First-in-human clinical trials for cancer and blood disorders

This series calls for clinical studies on novel agents for cancers and blood disorders. Summaries and reviews on first-in-human or first-in-class studies are also welcome.
 

How we treat image

xixinxing / Fotolia.

How we treat

This series will focus on guidelines, consensus, and multidisciplinary approaches on cancers and blood disorders. All submissions need to be pre-approved. Prospective authors should contact the Journal Development Manager for pre-approval at rosie.daniel@springer.com with an outline of their paper, the lead author name, and institution. 

 Manuscripts sponsored by pharmaceutical companies will not be considered.

weyo / stock.adobe.com

weyo / stock.adobe.com

New developments in delivery technology, materials, and molecular engineering for drug discovery

This series covers new technology, materials, and models for drug discovery. Development and applications of organoids, 3D cultures, PDX modes, nano-molecules, AI technology, and single-cell maps for drug discovery will be the focus. 

Thematic series

We are pleased to present two recent Journal of Hematology & Oncology thematic series:

Aims and scope

Journal of Hematology & Oncology is an open access, peer-reviewed online journal that encompasses all aspects of hematology and oncology. Read more.

Experimental Hematology & Oncology

Submit your research to our companion journal, Experimental Hematology & Oncology

Articles

Most recent articles RSS

View all articles

Most accessed articles RSS

View all articles

Springer Nature Oncology Portfolio

Discover the range of academic oncology titles at Springer Nature here.

CAHON: Stop hate crimes and racism

The Chinese American Hematologist and Oncologist Network (CAHON) has published an important and timely Editorial in the Journal of Hematology & Oncology. We are proud to stand with them in denouncing in the strongest terms all forms of discrimination and crimes against any racial/ethnic group, including Asian Americans and Pacific Islanders, and to call on our readers to pursue racial equality and tolerance in the USA and beyond. 

Editor's quote

"Journal of Hematology & Oncology provides a forum for top-quality research and is a leading title in hematology and oncology, with an Impact Factor ranked in Q1 in both categories. The journal also publishes reviews and research highlights from leading experts in the field. Research is shared with fast turnaround times in an open access format among laboratory scientists, physician scientists, hematologists and oncologists."

Prof Delong Liu, Editor-in-Chief, Journal of Hematology & Oncology

Latest Tweets

Your browser needs to have JavaScript enabled to view this timeline

JHO logo
Submit manuscript

Follow

Annual Journal Metrics

On the blog

Institutional membership

Visit the membership page to check if your institution is a member and learn how you could save on article-processing charges (APCs).

Funding your APC

​​​​​​​Open access funding and policy support by SpringerOpen​​

​​​​We offer a free open access support service to make it easier for you to discover and apply for article-processing charge (APC) funding. Learn more here. 

Journal of Hematology & Oncology

ISSN: 1756-8722

Contact us